Keloid pathogenesis and treatment

Plastic and Reconstructive Surgery

Volumn 117, Issue 1, 2006, Pages 286-300

  Al Attar, Ali ^a   Mess, Sarah ^a   Thomassen, John Michael ^a   Kauffman, C Lisa ^a   Davison, Steven P ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FLUOROURACIL; GROWTH FACTOR; INTERFERON; RETINOID; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; ANTIMETABOLITE; SILICONE GEL; TRANSFORMING GROWTH FACTOR BETA;

CELL DIFFERENTIATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEREDITY; HUMAN; KELOID; MUSCLE TONE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SEBUM; TURNOVER TIME; UNSPECIFIED SIDE EFFECT; FIBROBLAST; IMMUNOLOGY; INTRALESIONAL DRUG ADMINISTRATION; LASER; MECHANICAL STRESS; METABOLISM; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSURE;

ANTIMETABOLITES; COLLAGEN; COMBINED MODALITY THERAPY; EXTRACELLULAR MATRIX; FIBROBLASTS; FLUOROURACIL; HUMANS; INJECTIONS, INTRALESIONAL; INTERFERONS; KELOID; LASERS; PRESSURE; RETINOIDS; SEBUM; SILICONE GELS; STRESS, MECHANICAL; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE ACETONIDE;

EID: 33644850842     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000195073.73580.46     Document Type: Review

References (191)

1. Cohen, I. K., Keiser, H. R., and Sjoerdsma, A. Collagen synthesis in human keloid and hypertrophic scar. Surg. Forum 22: 488, 1971.
2. Craig, R. D. Collagen biosynthesis in normal human skin, normal and hypertrophic scar and keloid. Eur. J. Clin. Invest. 5: 69, 1975.
3. Breasted, J. H. The Edwin Smith surgical papyrus, Vol. 1. (hieroglyphic translation and commentary). Chicago: University of Chicago Press, 1930. Pp. 403-406.
4. Alibert, J. L. M. Description des maladies de la peau observees a l'hopital Saint-Louis et exposition des meilleures methodes suives pour leur traitment. Barrois l'aine et fils 113, 1806.
5. Cosman, B., Crikelair, G. F., Ju, D. M. C., Gaulin, J. C., and Lattes, R. The surgical treatment of keloids. Plast. Reconstr. Surg. 27: 335, 1961.
6. Mancini, R. E., and Quaife, J. V. Histogenesis of experimentally produced keloids J. Invest. Dermatol. 38: 143, 1962.
7. Peacock, E. E., Jr., Madden, J. W., and Trier, W. C. Biologic basis for the treatment of keloids and hypertrophic scars. South. Med. J. 63: 755, 1970.
8. Murray, J. C. Keloids and hypertrophic scars. Clin. Dermatol. 12: 27, 1994.
9. Muir, I. F. On the nature of keloid and hypertrophic scars. Br. J. Plast. Surg. 43: 61, 1990.
10. Nakaoka, H., Miyauchi, S., and Miki, Y. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Derm. Venereol. 75: 102, 1995.
11. Ehrlich, H. P., Desmouliere, A., Diegelmann, R., et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am. J. Pathol. 145: 105, 1994.
12. Blackburn, W. R., and Cosman, B. Histologic basis of keloid and hypertrophic scar differentiation: Clinicopathologic correlation. Arch. Pathol. 82: 65, 1966.
13. Hoopes, J. E., Su, C. T., and Im, M. J. Enzyme activities in hypertrophic scars and keloids. Plast. Reconstr. Surg. 47: 132, 1971.
14. Ueda, K., Furuya, E., Yasuda, Y., Oba, S., and Tajima, S. Keloids have continuous high metabolic activity. Plast. Reconstr. Surg. 104: 694, 1999.
15. Friedman, D. W., Boyd, C. D., Mackenzie, J. W., Norton, P., Olson, R. M., and Deak, S. B. Regulation of collagen gene expression in keloids and hypertrophic scars. J. Surg. Res. 55: 214, 1993.
16. Pierce, G. F., Tarpley, J. E., Yanagihara, D., Mustoe, T. A., Fox, G. M., and Thomason, A. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing: Neovessel and matrix formation and cessation of repair. Am. J. Pathol. 140: 1375, 1992.
17. Younai, S., Nichter, L. S., Wellisz, T., Reinisch, J., Nimni, M. E., and Tuan, T. L. Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts. Ann. Plast. Surg. 33: 148, 1994.
18. Bettinger, D. A., Yager, D. R., Diegelmann, R. F., and Cohen, I. K. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast. Reconstr. Surg. 98: 827, 1996.
19. Russell, S. B., Trupin, K. M., Rodriguez-Eaton, S., Russell, J. D., and Trupin, J. S. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc. Natl. Acad. Sci. U. S. A. 85: 587, 1988.
20. Peltonen, J., Hsiao, L. L., Jaakkola, S., et al. Activation of collagen gene expression in keloids: Co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J. Invest. Dermatol. 97: 240, 1991.
21. Younai, S., Venters, G., Vu, S., Nichter, L., Nimni, M. E., and Tuan, T. L. Role of growth factors in scar contraction: An in vitro analysis. Ann. Plast. Surg. 36: 495, 1996.
22. Kischer, C. W., Wagner, H. N., Jr., Pindur, J., et al. Increased fibronectin production by cell lines from hypertrophic scar and keloid. Connect. Tissue Res. 23: 279, 1989.
23. Pearlstein, E., Gold, L. I., and Garcia-Pardo, A. Fibronectin: A review of its structure and biological activity. Mol. Cell. Biochem. 29: 103, 1980.
24. Alaish, S. M., Yager, D. R., Diegelmann, R. F., and Cohen, I. K. Hyaluronic acid metabolism in keloid fibroblasts. J. Pediatr. Surg. 30: 949, 1995.
25. Hunzelmann, N., Anders, S., Sollberg, S., Schonherr, E., and Krieg, T. Co-ordinate induction of collagen type I and biglycan expression in keloids. Br. J. Dermatol. 135: 394, 1996.
26. Andriessen, M. P., Niessen, F. B., Van de Kerkhof, P. C., and Schalkwijk, J. Hypertrophic scarring is associated with epidermal abnormalities: An immunohistochemical study. J. Pathol. 186: 192, 1998.
27. Knighton, D. R., Hunt, T. K., Scheuenstuhl, H., Halliday, B. J., Werb, Z., and Banda, M. J. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221: 1283, 1983.
28. Kischer, C. W. The microvessels in hypertrophic scars, keloids and related lesions: A review. J. Submicrosc. Cytol. Pathol. 24: 281, 1992.
29. Kischer, C. W., Thies, A. C., and Chvapil, M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum. Pathol. 13: 819, 1982.
30. Kischer, C. W. Contributions of electron microscopy to the study of the hypertrophic scar and related lesions. Scanning Microsc. 7: 921, 1993.
31. Luo, S., Benathan, M., Raffoul, W., Panizzon, R. G., and Egloff, D. V. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast. Reconstr. Surg. 107: 87, 2001.
32. Milsom, J. P., and Craig, R. D. Collagen degradation in cultured keloid and hypertrophic scar tissue. Br. J. Dermatol. 89: 635, 1973.
33. Sollberg, S., Peltonen, J., and Uitto, J. Combined use of in situ hybridization and unlabeled antibody peroxidase anti-peroxidase methods: Simultaneous detection of type I procollagen mRNAs and factor VIII-related antigen epitopes in keloid tissue. Lab. Invest. 64: 125, 1991.
34. Diegelmann, R. F., Bryant, C. P., and Cohen, I. K. Tissue alpha-globulins in keloid formation. Plast. Reconstr. Surg. 59: 418, 1977.
35. Craig, R. D., Schofield, J. D., and Jackson, D. S. Collagen biosynthesis in normal and hypertrophic scars and keloid as a function of the duration of the scar. Br. J. Surg. 62: 741, 1975.
36. McCoy, B. J., Galdun, J., and Cohen, I. K. Effects of density and cellular aging on collagen synthesis and growth kinetics in keloid and normal skin fibroblasts. In Vitro 18: 79, 1982.
37. Matsuoka, L. Y., Uitto, J., Wortsman, J., Abergel, R. P., and Dietrich, J. Ultrastructural characteristics of keloid fibroblasts. Am. J. Dermatopathol. 10: 505, 1988.
38. Nakaoka, H., Miyauchi, S., and Miki, Y. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars. Acta Derm. Venereol. 75: 102, 1995.
39. Calderon, M., Lawrence, W. T., and Banes, A. J. Increased proliferation in keloid fibroblasts wounded in vitro. J. Surg. Res. 61: 343, 1996.
40. Tuan, T. L., Zhu, J. Y., Sun, B., Nichter, L. S., Nimni, M. E., and Laug, W. E. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J. Invest. Dermatol. 106: 1007, 1996.
41. Uchida, G., Yoshimura, K., Kitano, Y., Okazaki, M., and Harii, K. Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts. Exp. Dermatol. 12 Suppl. 2: 35, 2003.
42. Sussman, M. D. Effect of increased tissue traction upon tensile strength of cutaneous incisions in rats. Proc. Soc. Exp. Biol. Med. 123: 38, 1966.
43. Curtis, A. S., and Seehar, G. M. The control of cell division by tension or diffusion. Nature 274: 52, 1978.
44. Brody, G. S., Peng, S. T., and Landel, R. F. The etiology of hypertrophic scar contracture: Another view. Plast. Reconstr. Surg. 67: 673, 1981.
45. Courtiss, E. H., Longarcre, J. J., Destefano, G. A., Brizic, L., and Holmstrand, K. The placement of elective skin incisions. Plast. Reconstr. Surg. 31: 31, 1963.
46. Reiffel, R. S. Prevention of hypertrophic scars by long-term paper tape application. Plast. Reconstr. Surg. 96: 1715, 1995.
47. Anate, M. Skin closure of laparotomy wounds: Absorbable subcuticular sutures vs. non-absorbable interrupted sutures. West Afr. J. Med. 10: 150, 1991.
48. Brody, G. S. Keloids and hypertrophic scars. Plast. Reconstr. Surg. 86: 804, 1990.
49. Ogawa, R., Mitsuhashi, K., Hyakusoku, H., and Miyashita, T. Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: Retrospective study of 147 cases followed for more than 18 months. Plast. Reconstr. Surg. 111: 547, 2003.
50. Alhady, S. M., and Sivanantharajah, K. Keloids in various races: A review of 175 cases. Plast. Reconstr. Surg. 44: 564, 1969.
51. Cohen, I. K., McCoy, B. J., Mohanakumar, T., and Diegelmann, R. F. Immunoglobulin, complement, and histocompatibility antigen studies in keloid patients. Plast. Reconstr. Surg. 63: 689, 1979.
52. Ramakrishnan, K. M., Thomas, K. P., and Sundararajan, C. R. Study of 1,000 patients with keloids in South India. Plast. Reconstr. Surg. 53: 276, 1974.
53. Castagnoli, C., Peruccio, D., Stella, M., et al. The HLA-DR beta 16 allogenotype constitutes a risk factor for hypertrophic scarring. Hum. Immunol. 29: 229, 1990.
54. Laurentaci, G., and Dioguardi, D. HLA antigens in keloids and hypertrophic scars. Arch. Dermatol. 113: 1726, 1977.
55. Placik, O. J., and Lewis, V. L., Jr., Immunologic associations of keloids. Surg. Gynecol. Obstet. 175: 185, 1992.
56. Smith, C. J., Smith, J. C., and Finn, M. C. The possible role of mast cells (allergy) in the production of keloid and hypertrophic scarring J. Burn Care Rehabil. 8: 126, 1987.
57. Bloch, E. F., Hall, M. G., Jr., Denson, M. J., and Slay-Solomon, V. General immune reactivity in keloid patients. Plast. Reconstr. Surg. 73: 448, 1984.
58. Kazeem, A. A. The immunological aspects of keloid tumor formation. J. Surg. Oncol. 38: 16, 1988.
59. Janssen de Limpens, A. M. The local treatment of hypertrophic scars and keloids with topical retinoic acid. Br. J. Dermatol. 103: 319, 1980.
60. Murray, J. C., Pollack, S. V., and Pinnell, S. R. Keloids: A review. J. Am. Acad. Dermatol. 4: 461, 1981.
61. Curth, W., and McSorley, J. Multiple keloids. Arch. Dermatol. 104: 106, 1971.
62. Siraganian, P. A., Rubinstein, J. H., and Miller, R. W. Keloids and neoplasms in the Rubinstein-Taybi syndrome. Med. Pediatr. Oncol. 17: 485, 1989.
63. Hambrick, G. W., Jr., and Carter, D. M.Pachydermoperiostosis: Touraine-Solente-Gole syndrome. Arch. Dermatol. 94: 594, 1966.
64. Akintewe, T. A., and Alabi, G. O. Scleroderma presenting with multiple keloids. Br. Med. J. (Clin. Res. Ed.) 291: 448, 1985.
65. Hazrati, E., and Hoomand, A. The keloidal diathesis: A resistant state to malignancies? Plast. Reconstr. Surg. 59: 555, 1977.
66. Mukherjee, A., Mukherjee, A., and Saha, K. C. Delayed type hypersensitivity reaction to cutaneous antigen in keloid. Indian J. Dermatol. 27: 125, 1982.
67. Niessen, F. B., Spauwen, P. H., and Kon, M. The role of suture material in hypertrophic scar formation: Monocryl vs. Vicrylrapide. Ann. Plast. Surg. 39: 254, 1997.
68. Shetlar, M. R., Shetlar, C. L., Hendricks, L., and Kischer, C. W. The use of athymic nude mice for the study of human keloids. Proc. Soc. Exp. Biol. Med. 179: 549, 1985.
69. Estrem, S. A., Domayer, M., Bardach, J., and Cram, A. E. Implantation of human keloid into athymic mice. Laryngoscope 97: 1214, 1987.
70. Waki, E. Y., Crumley, R. L., and Jakowatz, J. G. Effects of pharmacologic agents on human keloids implanted in athymic mice: A pilot study. Arch. Otolaryngol. Head Neck Surg. 117: 1177, 1991.
71. Yagi, K. I., Dafalla, A. A., and Osman, A. A. Does an immune reaction to sebum in wounds cause keloid scars? Beneficial effect of desensitisation. Br. J. Plast. Surg. 32: 223, 1979.
72. Fong, E. P., Chye, L. T., and Tan, W. T. Keloids: Time to dispel the myths? Plast. Reconstr. Surg. 104: 1199, 1999.
73. Fong, E. P., and Bay, B. H. Keloids: The sebum hypothesis revisited. Med. Hypotheses 58: 264, 2002.
74. Fasika, O. M. Keloids: A study of the immune reaction to sebum. East Afr. Med. J. 69: 114, 1992.
75. Chytilova, M., Kulhanek, V., and Horn, V. Keloids as a form of auto-aggression in the scar. Rozhl. Chir. 39: 393, 1960.
76. Strauss, J. S. Radiation therapy of acne. Conn. Med. 23: 654, 1959.
77. Niessen, F. B., Spauwen, P. H., Schalkwijk, J., and Kon, M. On the nature of hypertrophic scars and keloids: A review. Plast. Reconstr. Surg. 104: 1435, 1999.
78. Mustoe, T. A., Cooter, R. D., Gold, M., et al. International clinical recommendations on scar management. Plast. Reconstr. Surg. 110: 560, 2002.
79. Bayat, A., Arscott, G., Ollier, W. E., Ferguson, M. W., and McGrouther, D. A. "Aggressive keloid": A severe variant of familial keloid scarring. J. R. Soc. Med. 96: 554, 2003.
80. Hollander, A. Intralesional injections of triamcinolone acetonide: A therapy for dermatoses. Antibiot. Med. Clin. Ther. 8: 78, 1961.
81. Murray, R. D. Kenalog and the treatment of hypertrophied scars and keloids in Negroes and whites. Plast. Reconstr. Surg. 31: 275, 1963.
82. Griffith, B. H. The treatment of keloids with triamcinolone acetonide. Plast. Reconstr. Surg. 38: 202, 1966.
83. Ketchum, L. D., Smith, J., Robinson, D. W., and Masters, F. W. The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plast. Reconstr. Surg. 38: 209, 1966.
84. Ketchum, L. D., Robinson, D. W., and Masters, F. W. Follow-up on treatment of hypertrophic scars and keloids with triamcinolone. Plast. Reconstr. Surg. 48: 256, 1971.
85. Griffith, B. H., Monroe, C. W., and McKinney, P. A. follow-up study on the treatment of keloids with triamcinolone acetonide. Plast. Reconstr. Surg. 46: 145, 1970.
86. McCoy, B. J., Diegelmann, R. F., and Cohen, I. K. In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc. Soc. Exp. Biol. Med. 163: 216, 1980.
87. Cruz, N. I., and Korchin, L. Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann. Plast. Surg. 33: 401, 1994.
88. Boyadjiev, C., Popchristova, E., and Mazgalova, J. Histomorphologic changes in keloids treated with Kenacort. J. Trauma 38: 299, 1995.
89. Kauh, Y. C., Rouda, S., Mondragon, G., et al. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J. Am. Acad. Dermatol. 37: 586, 1997.
90. Gadson, P. F., Russell, J. D., and Russell, S. B. Glucocorticoid receptors in human fibroblasts derived from normal dermis and keloid tissue. J. Biol. Chem. 259: 11236, 1984.
91. Friedman, S. J., Butler, D. F., and Pittelkow, M. R. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy: Report of two cases and review of the literature. J. Am. Acad. Dermatol. 19: 537, 1988.
92. Tang, Y. W. Intra- and postoperative steroid injections for keloids and hypertrophic scars. Br. J. Plast. Surg. 45: 371, 1992.
93. Darzi, M. A., Chowdri, N. A., Kaul, S. K., and Khan, M. Evaluation of various methods of treating keloids and hypertrophic scars: A 10-year follow-up study. Br. J. Plast. Surg. 45: 374, 1992.
94. Ritota, P. C., and Lo, A. K. Cushing's syndrome in postburn children following intralesional triamcinolone injection. Ann. Plast. Surg. 36: 508, 1996.
95. Teelucksingh, S., Balkaran, B., Ganeshmoorthi, A., and Arthur, P. Prolonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide. Ann. Trop. Paediatr. 22: 89, 2002.
96. Cosman, B., and Wolff, M. Correlation of keloid recurrence with completeness of local excision: A negative report. Plast. Reconstr. Surg. 50: 163, 1972.
97. Henderson, D. L. The effect of carbon dioxide laser surgery on the recurrence of keloids (Discussion). Plast. Reconstr. Surg. 87: 50, 1991.
98. Orgill, D. P., Straus, F. H., and Lee, R. C. The use of collagen-GAG membranes in reconstructive surgery. Ann. N.Y. Acad. Sci. 888: 233, 1999.
99. Levy, D. S., Salter, M. M., and Roth, R. E. Postoperative irradiation in the prevention of keloids. A.J.R. Am. J. Roentgenol. 127: 509, 1976.
100. Borok, T. L., Bray, M., Sinclair, I., Plafker, J., LaBirth, L., and Rollins, C. Role of ionizing irradiation for 393 keloids. Int. J. Radiat. Oncol. Biol. Phys. 15: 865, 1988.
101. Klumpar, D. I., Murray, J. C., and Anscher, M. Keloids treated with excision followed by radiation therapy. J. Am. Acad. Dermatol. 31: 225, 1994.
102. Ragoowansi, R., Cornes, P. G., Moss, A. L., and Glees, J. P. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast. Reconstr. Surg. 111: 1853, 2003.
103. Norris, J. E. Superficial x-ray therapy in keloid management: A retrospective study of 24 cases and literature review. Plast. Reconstr. Surg. 95: 1051, 1995.
104. Kovalic, J. J., and Perez, C. A. Radiation therapy following keloidectomy: A 20-year experience. Int. J. Radiat. Oncol. Biol. Phys. 17: 77, 1989.
105. Perkins, K., Davey, R. B., and Wallis, K. A. Silicone gel: A new treatment for burn scars and contractures. Burns Incl. Therm. Inj. 9: 201, 1983.
106. Quinn, K. J., Evans, J. H., Courtney, J. M., Gaylor, J. D., and Reid, W. H. Non-pressure treatment of hypertrophic scars. Burns Incl. Therm. Inj. 12: 102, 1985.
107. Quinn, K. J. Silicone gel in scar treatment. Burns Incl. Therm. Inj. 13 (Suppl.): S33, 1987.
108. Ahn, S. T., Monafo, W. W., and Mustoe, T. A. Topical silicone gel: A new treatment for hypertrophic scars. Surgery 106: 781, 1989.
109. Ahn, S. T., Monafo, W. W., and Mustoe, T. A. Topical silicone gel for the prevention and treatment of hypertrophic scar. Arch. Surg. 126: 499, 1991.
110. Clugston, P. A., Vistnes, M. D., Perry, L. C., Maxwell, G. P., and Fisher, J. Evaluation of silicone-gel sheeting on early wound healing of linear incisions. Ann. Plast. Surg. 34: 12, 1995.
111. Sproat, J. E., Dalcin, A., Weitauer, N., and Roberts, R. S. Hypertrophic sternal scars: Silicone gel sheet versus Kenalog injection treatment. Plast. Reconstr. Surg. 90: 988, 1992.
112. Gold, M. H. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J. Am. Acad. Dermatol. 30: 506, 1994.
113. Davey, R. B., Wallis, K. A., and Bowering, K. Adhesive contact media: An update on graft fixation and burn scar management. Burns 17: 313, 1991.
114. Sawada, Y., and Sone, K. Hydration and occlusion treatment for hypertrophic scars and keloids. Br. J. Plast. Surg. 45: 599, 1992.
115. Chang, C. C., Kuo, Y. F., Chiu, H. C., Lee, J. L., Wong, T. W., and Jee, S. H. Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. J. Surg. Res. 59: 705, 1995.
116. Fulton, J. E., Jr., Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol. Surg. 21: 947, 1995.
117. Cruz-Korchin, N. I. Effectiveness of silicone sheets in the prevention of hypertrophic breast scars. Ann. Plast. Surg. 37: 345, 1996.
118. Brent, B. The role of pressure therapy in management of ear-lobe keloids: Preliminary report of a controlled study. Ann. Plast. Surg. 1: 579, 1978.
119. Mercer, D. M., and Studd, D. M. "Oyster splints": A new compression device for the treatment of keloid scars of the ear. Br. J. Plast. Surg. 36: 75, 1983.
120. Pierce, H. E. Postsurgical acrylic ear splints for keloids. J. Dermatol. Surg. Oncol. 12: 583, 1986.
121. Hurtado, A. J., and Crowther, D. S. Methyl methacrylate stent for prevention of postexcisional recurrent ear keloid. J. Prosthet. Dent. 54: 245, 1985.
122. Linares, H. A., Larson, D. L., and Willis-Galstaun, B. A. Historical notes on the use of pressure in the treatment of hypertrophic scars or keloids. Burns 19: 17, 1993.
123. Snyder, G. B. Button compression for keloids of the lobule. Br. J. Plast. Surg. 27: 186, 1974.
124. Lawrence, W. T. Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings. Ann. Plast. Surg. 37: 167, 1996.
125. Agrawal, K., Panda, K. N., and Arumugam, A. An inexpensive self fabricated pressure clip for the ear lobe. Br. J. Plast. Surg. 51: 122, 1998.
126. Russell, R., Horlock, N., and Gault, D. Zimmer splintage: A simple effective treatment for keloids following ear-piercing. Br. J. Plast. Surg. 54: 509, 2001.
127. Nason, K. H. Keloids and their treatment. N. Engl. J. Med. 226: 883, 1942.
128. Kischer, C. W., Shetlar, M. R., and Shetlar, C. L. Alteration of hypertrophic scars induced by mechanical pressure. Arch. Dermatol. 111: 60, 1975.
129. Norris, J. E. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast. Reconstr. Surg. 87: 44, 1991.
130. Henderson, D. L., Cromwell, T. A., and Mes, L. G. Argon and carbon dioxide laser treatment of hypertrophic and keloid scars. Lasers Surg. Med. 3: 271, 1984.
131. Kaplan, I. Current CO2 laser surgery. Plast. Reconstr. Surg. 69: 552, 1982.
132. Conejo-Mir, J. S., Corbi, R., and Linares, M. Carbon dioxide laser ablation associated with interferon alfa-2b injections reduces the recurrence of keloids. J. Am. Acad. Dermatol. 39: 1039, 1998.
133. Alster, T. S. Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser. Ann. Plast. Surg. 32: 186, 1994.
134. Alster, T. S., and Williams, C. M. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet 345: 1198, 1995.
135. Goldman, M. P., and Fitzpatrick, R. E. Laser treatment of scars. Dermatol. Surg. 21: 685, 1995.
136. Dierickx, C., Goldman, M. P., and Fitzpatrick, R. E. Laser treatment of erythematous/hypertrophic and pigmented scars in 26 patients. Plast. Reconstr. Surg. 95: 84, 1995.
137. Alster, T. S. Laser treatment of hypertrophic scars, keloids, and striae. Dermatol. Clin. 15: 419, 1997.
138. Anderson, R. R., Margolis, R. J., Watenabe, S., Flotte, T., Hruza, G. J., and Dover, J. S. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J. Invest. Dermatol. 93: 28, 1989.
139. Fitzpatrick, R. E. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol. Surg. 25: 224, 1999.
140. Uppal, R. S., Khan, U., Kakar, S., Talas, G., Chapman, P., and McGrouther, A. D. The effects of a single dose of 5-fluorouracil on keloid scars: A clinical trial of timed wound irrigation after extralesional excision. Plast. Reconstr. Surg. 108: 1218, 2001.
141. Manuskiatti, W., and Fitzpatrick, R. E. Treatment response of keloidal and hypertrophic sternotomy scars: Comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch. Dermatol. 138: 1149, 2002.
142. Blumenkranz, M. S., Ophir, A., Claflin, A. J., and Hajek, A. Fluorouracil for the treatment of massive periretinal proliferation. Am. J. Ophthalmol. 94: 458, 1982.
143. Harrop, A. R., Ghahary, A., Scott, P. G., Forsyth, N., Uji-Friedland, A., and Tredget, E. E. Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma. J. Surg. Res. 58: 471, 1995.
144. Berman, B., and Duncan, M. R. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J. Am. Acad. Dermatol. 21: 694, 1989.
145. Tredget, E. E., Nedelec, B., Scott, P. G., and Ghahary, A. Hypertrophic scars, keloids, and contractures: The cellular and molecular basis for therapy. Surg. Clin. North Am. 77: 701, 1997.
146. Tredget, E. E., Shankowsky, H. A., Pannu, R., et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: Effects of interferon alpha-2b. Plast. Reconstr. Surg. 102: 1317, 1998.
147. Larrabee, W. F., Jr., East, C. A., Jaffe, H. S., Stephenson, C., and Peterson, K. E. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch. Otolaryngol. Head Neck Surg. 116: 1159, 1990.
148. Granstein, R. D., Rook, A., Flotte, T., et al. A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring: Clinical and histologic findings. Arch. Dermatol. 126: 1295, 1990.
149. Broker, B. J., Rosen, D., Amsberry, J., et al. Keloid excision and recurrence prophylaxis via intradermal interferon-gamma injections: A pilot study. Laryngoscope 106: 1497, 1996.
150. Espinassouze, F., Heid, E., and Grosshans, E. Treatment of keloid by intralesional injections of interferon alfa-2B (in French). Ann. Dermatol. Venereol. 120: 629, 1993.
151. Wong, T. W., Chiu, H. C., and Yip, K. M. Intralesional interferon alpha-2b has no effect in the treatment of keloids. Br. J. Dermatol. 130: 683, 1994.
152. al Khawajah, M. M. Failure of interferon-alpha 2b in the treatment of mature keloids. Int. J. Dermatol. 35: 515, 1996.
153. Berman, B., and Flores, F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J. Am. Acad. Dermatol. 37: 755, 1997.
154. Prutkin, L. Wound healing and vitamin A acid. Acta Derm. Venereol. 52: 489, 1972.
155. Christophers, E. Growth stimulation of cultured postembryonic epidermal cells by vitamin A acid. J. Invest. Dermatol. 63: 450, 1974.
156. Christophers, E., and Wolff, H. H. Differential formation of desmosomes and hemidesmosomes in epidermal cell cultures treated with retinoic acid. Nature 256: 209, 1975.
157. Daly, T. J., Golitz, L. E., and Weston, W. L. A double-blind placebo-controlled efficacy study on tretinoin cream 0.05% in the treatment of keloids and hypertrophic scars. J. Invest. Dermatol. 86: 470, 1986.
158. Daly, T. J., and Weston, W. L. Retinoid effects on fibroblast proliferation and collagen synthesis in vitro and on fibrotic disease in vivo. J. Am. Acad. Dermatol. 15: 900, 1986.
159. Nelson, D. L., and Balian, G. The effect of retinoic acid on collagen synthesis by human dermal fibroblasts. Coll. Relat. Res. 4: 119, 1984.
160. Abergel, R. P., Meeker, C. A., Oikarinen, H., Oikarinen, A. I., and Uitto, J. Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures. Arch. Dermatol. 121: 632, 1985.
161. Sporn, M. B., Roberts, A. B., Roche, N. S., Kagechika, H., and Shudo, K. Mechanism of action of retinoids. J. Am. Acad. Dermatol. 15: 756, 1986.
162. D'Andrea, F., Brongo, S., Ferraro, G., and Baroni, A. Prevention and treatment of keloids with intralesional verapamil. Dermatology 204: 60, 2002.
163. Copcu, E., Sivrioglu, N., and Oztan, Y. Combination of surgery and intralesional verapamil injection in the treatment of the keloid. J. Burn Care Rehabil. 25: 1, 2004.
164. Lee, R. C., and Ping, J. A. Calcium antagonists retard extracellular matrix production in connective tissue equivalent. J. Surg. Res. 49: 463, 1990.
165. Lee, R. C., Doong, H., and Jellema, A. F. The response of burn scars to intralesional verapamil: Report of five cases. Arch. Surg. 129: 107, 1994.
166. Doong, H., Dissanayake, S., Gowrishankar, T. R., LaBarbera, M. C., and Lee, R. C. The 1996 Lindberg Award: Calcium antagonists alter cell shape and induce procollagenase synthesis in keloid and normal human dermal fibroblasts. J. Burn Care Rehabil. 17: 497, 1996.
167. Layton, A. M., Yip, J., and Cunliffe, W. J. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br. J. Dermatol. 130: 498, 1994.
168. Har-Shai, Y., Amar, M., and Sabo, E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast. Reconstr. Surg. 111: 1841, 2003.
169. Sandberg, N. Accelerated collagen formation and histamine. Nature 194: 183, 1962.
170. Topol, B. M., Lewis, V L., Jr., and Benveniste, K. The use of antihistamine to retard the growth of fibroblasts derived from human skin, scar, and keloid. Plast. Reconstr. Surg. 68: 227, 1981.
171. Cohen, I. K., Beaven, M. A., Horakova, Z., and Keiser, H. R. Histamine and collagen synthesis in keloid and hypertrophic scar. Surg. Forum 23: 509, 1972.
172. Bairy, K. L., Rao, C. M., Ramesh, K. V., and Kulkarni, D. R. Effect of histamine on wound healing. Indian J. Physiol. Pharmacol. 35: 180, 1991.
173. Peacock, E. E., Jr., Pharmacologic control of surface scarring in human beings. Ann. Surg. 193: 592, 1981.
174. Bodokh, I., and Brun, P. Treatment of keloid with intralesional bleomycin (in French). Ann. Dermatol. Venereol. 123: 791, 1996.
175. Carnero, L., Silvestre, J. F., Guijarro, J., Albares, M. P., and Botella, R. Nuchal acne keloidalis associated with cyclosporin. Br. J. Dermatol. 144: 429, 2001.
176. Espana, A., Solano, T., and Quintanilla, E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol. Surg. 27: 23, 2001.
177. Berman, B., and Kaufman, J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J. Am. Acad. Dermatol. 47: S209, 2002.
178. Berman, B., and Villa, A. Imiquimod 5% cream for keloid management. Dermatol. Surg. 29: 1050, 2003.
179. Duncan, J. I., Thomson, A. W., and Muir, I. F. Topical cyclosporin and T lymphocytes in keloid scars. Br. J. Dermatol. 124: 109, 1991.
180. Craig, R. D., and Pearson, D. Early post-operative irradiation in the treatment of keloid scars. Br. J. Plast. Surg. 18: 369, 1965.
181. Doornbos, J. F., Stoffel, T. J., Hass, A., et al. The role of kilo-voltage irradiation in the treatment of keloids. Int. J. Radiat. Oncol. Biol. Phys. 18: 833, 1990.
182. Polo, M., Smith, P. D., Kim, Y. J., Wang, X., Ko, F., and Robson, M. C. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Ann. Plast. Surg. 43: 185, 1999.
183. Border, W. A., and Noble, N. A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331: 1286, 1994.
184. Shah, M., Foreman, D. M., and Ferguson, M. W. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 339: 213, 1992.
185. Shah, M., Foreman, D. M., and Ferguson, M. W. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J. Cell Sci. 107: 1137, 1994.
186. Shah, M., Foreman, D. M., and Ferguson, M. W. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 108: 985, 1995.
187. Tyrone, J. W., Marcus, J. R., Bonomo, S. R., Mogford, J. E., Xia, Y., and Mustoe, T. A. Transforming growth factor beta3 promotes fascial wound healing in a new animal model. Arch. Surg. 135: 1154, 2000.
188. Lim, I. J., Phan, T. T., Song, C., Tan, W. T., and Longaker, M. T. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast. Reconstr. Surg. 107: 797, 2001.
189. Lim, I. J., Phan, T. T., Bay, B., et al. Fibroblasts cocultured with keloid keratinocytes: Normal fibroblasts secrete collagen in a keloidlike manner. Am. J. Physiol 283: C212, 2002.
190. Phan, T. T., Lim, I. J., Bay, B., et al. Differences in collagen production between normal and keloid-derived fibroblasts in serum-media co-culture with keloid-derived keratinocytes. J. Dermatol. Sci. 29: 26, 2002.
191. Morris, D. E., Wu, L., Zhao, L., et al. Acute and chronic animal models for excessive dermal scarring: Quantitative studies. Plast. Reconstr. Surg. 100: 674, 1997.